Author index (vol. 91)

Author index (vol. 91)

Atherosclerosis, Y1 (I YY1) 285-287 c 1991 Elsevier Scientific Publishers 285 Ireland, Ltd. All rights reserved 0021-9150/91/$03.50 Author Index (...

204KB Sizes 0 Downloads 110 Views

Atherosclerosis, Y1 (I YY1) 285-287 c 1991 Elsevier Scientific Publishers

285 Ireland,

Ltd. All rights reserved

0021-9150/91/$03.50

Author Index (Vol. 91)

Venous occlusion and chronic cigarette smoking: dose-dependent decrease in the measurable release of tissue-type plasminogen activator and von Willebrand factor (91) 247

Arakawa. K., see Zhang. B. (91) 277 Araki. G.. see Homma. Y. (91) 145 Aston. C.E.. see Kamboh, M.I. (91) 25 Avogaro. P.. Cazzolato, G. and Bittolo-Bon, G. Some questions concerning a small, more electronegative LDL circulating in human plasma (Yll 163 Betteridge. D.J.. see Jay, R.H. (91) 117 Bhakdi. S., see Seifert, P.S. (91) i55 Bittolo-Bon. G., see Avogaro. P. (91) 163 Brun. S.. see Gris. J.C. (91) 247 Brunschwig, C.. see Gris. J.C. (911 247 Carmelli, D.. see Lamon-Fava, S. (91) 97 Castelli. W.P.. see Lamon-Fava, S. (91) 97 Cazzolato, G.. see Avogaro. P. (91) 163 Christian. J.C.. see Lamon-Fava, S. (91) 97 Clair. R.W.S.. see Sulistiyani. (91) 123 Conlan. M.G.. see Folsom. A.R. (91) 191 Cooper. J.P. and Newby. A.C. Monocyte adhesion to human saphenous 8.5

vein in vitro (91)

Davis. C.E.. see Folsom, A.R. (91) 191 De Servi. S., see Ricevuti, G. (91) 1 Ditschuneit. H., see Stange, E.F. (91) 257 Ditschuneit, H.H., see Stange, E.F. (91) 257 Droidi. M.. see Gminski, J. (91) 185 Dudman. N.P.B.. Hicks, C.. Wang, J. and Wilcken. D.E.L. Human arterial endothelial cell detachment in vitro: promotion by homocysteine and cysteine (91) 77 Durham. S.K.. see Kowala, M.C. (91) 35

Hagihara. H., Nomoto. A.. Mutoh. S.. Yamaguchi. I. and One. T. Role of inflammatory responses in initiation of atherosclerosis: effects of anti-inflammatory drugs on cuff-induced leukocyte accumulation and intimal thickening of rabbit carotid artery (91) 107 Hamman, R.F.. see Kamboh. M.I. (91) 25 Harders-Spengel, K., see Wade, D.P. (91) 63 Hawley, M.S., see Mangion, D.M. (91) 137 Hicks. C., see Dudman, N.P.B. (91) 77 Hirata. K.. see Zhang. B. (91) 277 Homma, Y., Ohshima. K., Yamaguchi, H.. Nakamura. H.. Araki. G. and Goto, Y. Effects of eicosapentaenoic acid on plasma lipoprotein subfractions and activities of 1ecithin:cholesterol acyltransferase and lipid transfer protein (91) 145 Howard, B.V., see Patti. L. (91) 15 Humphries. S.E., see Renges, H.-H. (91) 267 Iyengar,

its

Fabsitz, R.R.. see Lamon-Fava, S. (91) 97 Ferrell. R.E.. see Kamboh, M.I. (91) 25 Folsom. A.R.. Wu. K.K.. Davis, C.E.. Conlan, M.G., Sorlie, P.D. and Szklo. M. Population correlates of plasma fibrinogen and factor VII, putativje cardiovascular risk factors (91) 191 Gallagher. J.J.. see Maher, V.M.G. (91) 73 Gminski, J.. Drozdi. M.. Ulfig-MaSlanka. R. and Najda, J. Evaluation of e&tin metabolism in children from families with high risk of atherosclerosis (91) 185 Goto. Y.. see Homma, Y. (91) 145 Gris. J.C., Schved. J.F., Brun, S., Brunschwig, C.. Petris, I., Lassonnery. M., Martinez. P. and Sarlat, C.

S., see Kamboh,

M.I. (91) 25

Jay, R.H.. McCarthy, S.N.. Rampling. M.W. and Betteridge, D.J. Blood rheology and fibrinogen in children with familial hypercholesterolaemia (91) 117 Jimenez. D., see Lamon-Fava, S. (9 1) 97 Johansson. J., Molgaard, J. and Olsson. A.G. Plasma high density lipoprotein particle size alteration by simvastatin treatment in patients with hypercholesterolaemia (91) 175 Jouni, Z.E., see Shi, F. (91) 217 Kamanna, V.S.. see Kirschenbaum, M.A. (91) 241 Kamboh, MI., Hamman, R.F.. Iyengar. S.. Aston. C.E. and Ferrell, R.E. Apolipoprotein A-IV polymorphism. and its role in determining variation in lipoprotein-lipid, glucose and insulin levels in normal and non-insulin-dependent diabetic individuals (91) 25 Kirschenbaum, M.A., Roh, D.D. and Kamanna. VS. Effect of nifedipine on renal microvascular cholesterol accumulation and prostacyclin biosynthesis in cholesterolfed rabbits (91) 241

286 Knight, B.L., see Wade, D.P. (91) 63 Kowala, M.C., Nunnari, J.J., Durham, S.K. and Nicolosi, R.J. Doxazosin and cholestyramine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamsters (91) 35 Lamon-Fava, S., Jimenez, D., Christian, J.C., Fabsitz, R.R., Reed, T., Carmelli, D., Castelli, W.P., Ordovas, J.M., Wilson, P.W.F. and Schaefer, E.J. The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a) (91) 97 Lassonnery, M., see Gris, J.C. (91) 247 Liu, R., see Zhang, B. (91) 277 Maher, V.M.G., Gallagher, J.J., Thompson, G.R. and Myant, N.B. Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100 (91) 73 Mangion, D.M., Hawley, M.S. and Norcliffe, D. Lower limb arterial disease: assessment of risk factors in an elderly population (91) 137 Marmot, M.G., see Renges, H.-H. (91) 267 Martinez, P., see Gris, J.C. (91) 247 Mazzone, A., see Ricevuti, G. (91) 1 McCarthy, S.N., see Jay, R.H. (91) 117 McKeigue, P.M., see Renges, H.-H. (911 267 McNamara, D.J., see Shi, F. (91) 217 Messner, M., see Seifert, P.S. (91) 155 Miilgaard, J., see Johansson, J. (91) 175 Morimatsu, M., see Yanagi, H. (91) 207 Mutoh, S., see Hagihara, H. (91) 107 Myant, N.B., see Maher, V.M.G. (91) 73 Nagase, H., see Yanagi, H. (91) 207 Najda, J., see Gmifiski, J. (91) 185 Nakamura, H., see Homma, Y. (91) 145 Newby, A.C., see Cooper, J.P. (91) 85 Nicolosi, R.J., see Kowala, M.C. (91) 35 Nomoto, A., see Hagihara, H. (91) 107 Norcliffe, D., see Mangion, D.M. (91) 137 Nunnari, J.J., see Kowala, M.C. (91) 35 Ohshima, K., see Homma, Y. (911 145 Olsson, A.G., see Johansson, J. (91) 175 Ono, T., see Hagihara, H. (91) 107 Ordovas, J.M., see Lamon-Fava, S. (91) 97 Osenbriigge, M., see Stange, E.F. (91) 257 Owens, R.T. and Wagner, W.D. Proteoglycans produced by cholesterol-enriched macrophages bind plasma low density lipoprotein (91) 229 Pasotti, D., see Ricevuti, G. (91) 1 Patti, L., Swinburn, B., Riccardi, G., Rivellese, A.A. and Howard, B.V. Alterations in very low density lipoprotein subfractions in normotriglyceridemic non-insulin-dependent diabetics (91) 15 Petris, I., see Gris, J.C. (91) 247

Rampling, M.W., see Jay, R.H. (91) 117 Reed, T., see Lamon-Fava, S. (91) 97 Reimann, F., see Stange, E.F. (91) 257 Renges, H.-H., Wile, D.B., McKeigue, P.M., Marmot, M.G. and Humphries, S.E. Apolipoprotein B gene polymorphisms are associated with lipid levels in men of South Asian descent (91) 267 Riccardi, G., see Patti, L. (91) 15 Ricevuti, G., Mazzone, A., Pasotti, D., De Servi, S. and Specchia, G. Role of granulocytes in endothelial injury in coronary heart disease in humans (91) 1 Rivellese, A.A., see Patti, L. (91) 15 Roh, D.D., see Kirschenbaum, M.A. (91) 241 Roth, I., see Seifert, P.S. (91) 155 Rustan, M., see Stange, E.F. (91) 257 Saku, K., see Zhang, B. (91) 277 Sarlat, C., see Gris, J.C. (91) 247 Sasaguri, Y., see Yanagi, H. (91) 207 Schaefer, E.J., see Lamon-Fava, S. (91) 97 Schneider, A., see Stange, E.F. (91) 257 Schved, J.F., see Gris, J.C. (91) 247 Seifert, P.S., Messner, M., Roth, I. and Bhakdi, S. Analysis of complement C3 activation products in human atherosclerotic lesions (91) 155 Shi, F., Jouni, Z.E. and McNamara, D.J. Reduced regulatory capacity of low density lipoproteins from patients with coronary artery disease (91) 217 Sorlie, P.D., see Folsom, A.R. (91) 191 Soutar, A.K., see Wade, D.P. (91) 63 Specchia, G., see Ricevuti, G. (91) 1 Stange, E.F., Osenbriigge, M., Rustan, M., Reimann, F., Schneider, A., Ditschuneit, H.H. and Ditschuneit, H. Inhibition of HMG-CoA reductase in mononuclear cells during gemfibrozil treatment (91) 257 Sugama, K., see Yanagi, H. (91) 207 Sulistiyani, and Clair, R.W.S. The method of isolation of primary cells and their subculture influences the expression of LDL receptors on pigeon and chicken embryo cells in culture (91) 123 Swinburn, B., see Patti, L. (91) 15 Szklo, M., see Folsom, A.R. (91) 191 Tam, S.-P. Effects of gemfibrozil and ketoconazole on human apolipoprotein AI, B and E levels in two hepatoma cell lines, HepG2 and Hep3B (91) 51 Tateishi, K., see Zhang, B. (91) 277 Thompson, G.R., see Maher, V.M.G. (91) 73 Ulfig-Maslanka,

R., see Gmihski,

J. (91) 185

Wade, D.P., Knight, B.L., Harders-Spengel, K. and Soutar, A.K. Detection and quantitation of apolipoprotein(a) mRNA in human liver and its relationship with plasma lipoprotein(a) concentration (91) 63

287 Wagner, W.D., see Owens, R.T. (91) 229 Wang, J.. see Dudman, N.P.B. (91) 77 Wilcken, D.E.L., see Dudman, N.P.B. (91) 77 Wile. D.B., see Renges, H.-H. (91) 267 Wilson. P.W.F., see Lamon-Fava, S. (91) 97 Wu. K.K., see Folsom, A.R. (91) 191

Yanagi, H., Sasaguri, Y., Sugama, K., Morimatsu, M. and Nagase, H. Production of tissue collagenase (matrix metalloproteinase 1) by human aortic smooth muscle cells in response to platelet-derived growth factor (91) 207

Yamaguchi. Yamaguchi, Yamamoto.

Zhang, B., Saku, K., Hirata. mamoto, K. and Arakawa, Insulin resistance observed

H., see Homma, Y. (91) 145 I., see Hagihara, H. (91) 107 K., see Zhang, B. (91) 277

K., Liu, R., Tateishi, K., YaK. in WHHL rabbits (91) 277